Qanatpharma

A Swiss & Toronto based innovative pharma company bringing solutions to microvascular medicine.

[Ted Rogers Centre for Heart Research @trogersresearch]

Learn about @qanatpharma's success and technologies at tomorrow's #ECHO webinar with founder, Prof. Steffen-Sebastian Bolz @SteffenSebasti3! There's still time to register:
📅 Tuesday, Jan 31
⏲️ 11am - 12pm
🔗 https://t.co/ZtdGwx65x8

[Stroke AHA/ASA @StrokeAHA_ASA]

#BloggingStroke: Microvascular Circadian Rhythmicity and Subarachnoid Hemorrhage-Induced Injury https://t.co/WWo88UZLZ3
In this blog post, @KShkirkova discusses #Stroke article https://t.co/wBzOblA4dd

[Ted Rogers Centre for Heart Research @trogersresearch]

Join us for an #ECHO webinar featuring Prof. Steffen-Sebastian Bolz, who will provide an overview of Qanatpharma, its technologies and the story behind its success.
📅Tuesday, Jan 31, 2023
⏲️11am - 12pm
Register now: https://t.co/ZtdGwx5xHA

[Qanatpharma @qanatpharma]

Find our latest work, "Disrupting circadian control of peripheral myogenic reactivity mitigates cardiac injury following myocardial infarction", indicating therapeutics targeting the molecular clock may be useful for improving MI outcomes.

https://t.co/RjvIBsy2AU